Michael J. Pellini - 25 May 2023 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 May 2023
Net transactions value
$0
Form type
4
Filing time
26 May 2023, 17:04:46 UTC
Previous filing
08 Mar 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 25 May 2023 Common Stock 100,000 $1.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest and become exercisable upon the earlier of the 2024 Stockholder Annual Meeting or May 25, 2024.